In 2017 the journal Sexually Transmitted Diseases (STI) published a series of 300 word vignettes celebrating the centenary of genitourinary medicine services in the UK. Each invited piece was to be based on two articles published in STI or its predecessors (Genitourinary Medicine, and the British Journal of Venereal Diseases). I chose to feature gonococcal culture 1 and referenced two of our speciality's great names, Harrison 2 and Catterall 3 . I was asked to provide a longer 'blog' on the topic but, as this contribution is only available to the Journal's online subscribers, there is no printed version. The piece that follows is an expanded argument based on, and includes a little material from, the STI contribution and revisits a topic to which I have returned over the years at The College's Annual Academic Sessions [4] [5] [6] [7] .
There were significant improvements in laboratory culture of gonorrhoea during the 1970s but it was 30 years before revolutionary techniques for diagnosis became commercially available. These alternative tests, Nucleic Acid Amplification Tests (NAATs), were simpler to administer, but their introduction brought loss of personnel and diminished need for microscopy and laboratory skills. They also introduced a 'commercial imperative' -makers of diagnostic tests need to recoup their development costs and produce profit for themselves and their shareholders. For this they have to show superiority over laboratory culture.
I highlighted this potential conflict of interest in my 2012 talk 6 with an allegory of a carrot farmer presented with a new commercial test for identifying his produce. While this test was claimed to be superior to the traditional 'see, touch, taste method', it was expensive and from time to time identified a turnip as a carrot.
Laboratory culture of Neisseria gonorrhoeae lacks, and has always lacked, 100% sensitivity. In the pre-NAAT era, samples were taken from multiple sites, on multiple occasions, to diagnose, to exclude, and, importantly, to monitor any fluctuations, in the efficiency of laboratory culture. Such use of repeated tests to monitor the sensitivity of culture is now impossible following the universal adoption of treatment of contacts (epidemiological) before diagnosis.
In the 1970s, tests were taken on at least three separate occasions to diagnose or exclude gonorrhoea in women. Even with multiple sets of tests, the culture results varied significantly between Centres.
The decade was marked by attempts at improving cultural sensitivity: a variety of selective but non-inhibitory mediums, usually modifications of Thayer-Martin's version, gradually replaced non-selective ones. Catterall however used McLeod's culture medium, with no antibiotics or antifungal agents, and only diagnosed 60% of gonorrhoea at the first visit. In the 1970s, as now, we had Reference Laboratories, guidelines, and exhortations to quality control and yet there was still a measurable variation in outcomes of gonococcal culture between and within London's 'Centres of Excellence'. Before I am overwhelmed by howls of protest from microbiologists (and epidemiologists), I wonder how many laboratories, whose 'culture' results provide today's comparators for epidemiological and NAAT evaluations, look, have looked, at the performance of their transport/culture systems 22, 23 , in a similarly fastidious way?
What proportion of clinics or testing sites these days have all the index samples plated direct in clinic on to an appropriate selective but non-inhibitory medium (made up inhouse as required, not commercial 23 ), and placed directly in the clinic's CO 2 / humidity/ temperature-controlled incubator, with samples transferred to the on-site laboratory (dedicated gonorrhoea bench, dedicated gonorrhoea technician) twice daily, and with daily quality control to include correlation of microscopy of samples from the male urethra with their culture results.
This crucial monitoring of men's samples enabled us to pick up problems with the incubators (clinic and laboratory), growth medium, a new technician on the 'GC' bench,
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or even sloppy plating-out in the clinic. If a discrepancy arose, we were aware of it in as few as 24 hours and were able to adjust our management of women, for whom culture was (and should still be) of so much greater importance.
While matching the earlier paragraph's stringent conditions, culture in 1988 at St Thomas' still missed 3% of cases of gonorrhoea in women at the first attempt 19 .
Nobody would disagree with the conclusion of a recent STI article 24 
